Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic ImpairmentJohn P. Gibbs, Maurice G. Emery, Jessica Johnson et al.|The Journal of Clinical Pharmacology|2016Cited by 25
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Christopher Fotsch, David J. St. Jean et al.|ACS Medicinal Chemistry Letters|2011Cited by 21
Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidateXiaochun Zhu, Raju Subramanian, J. Greg Slatter et al.|Xenobiotica|2012Cited by 5
Regiospecific and Stereospecific Triangulation of the Structures of Metabolites Formed by Sequential Metabolism at Multiple Prochiral CentersRobert J. Greene, J. Greg Slatter, John A. Davis et al.|Drug Metabolism and Disposition|2012Cited by 4